Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

NCT03357653 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis, Immunoglobulin A (IgA)

Interventions

DRUG: Losartan group
DRUG: Placebo group

Sponsor

Ewha Womans University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]